Medibank Pvt (ASX:MPL) 1-Year Sharpe Ratio: -0.42 (As of Jul. 12, 2026)


ASX:MPL Medibank Pvt Ltd ASX:MPL
77 GF Score
Price A$5.04
GF Value A$4.40
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Medibank Pvt 1-Year Sharpe Ratio?

Medibank Pvt ASX:MPL 77 1-Year Sharpe Ratio is -0.42 as of Jul. 12, 2026. GuruFocus rates ASX:MPL with a GF Score™ of 77/100 and a GF Value™ of A$4.40 (Modestly Overvalued). The stock has 6 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-07-12), Medibank Pvt's 1-Year Sharpe Ratio is -0.42.

Medibank Pvt  (ASX:MPL) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

Medibank Pvt 1-Year Sharpe Ratio Related Terms

ASX:MPL vs FNF, AXS, FAF: 1-Year Sharpe Ratio Comparison

For the Insurance - Specialty subindustry, Medibank Pvt's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medibank Pvt 1-Year Sharpe Ratio vs Insurance Industry

For the Insurance industry and Financial Services sector, Medibank Pvt's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Medibank Pvt's 1-Year Sharpe Ratio falls into.


ASX:MPL
77GF Score
Medibank Pvt Ltd ASX:MPL
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medibank Pvt 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of -0.42 mean?
Medibank Pvt (ASX:MPL) has a 1-Year Sharpe Ratio of -0.42 as of Jul. 12, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Medibank Pvt and its competitors.
Is Medibank Pvt's 1-Year Sharpe Ratio too high?
Medibank Pvt's current 1-Year Sharpe Ratio is -0.42. Overall, Medibank Pvt has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medibank Pvt's 1-Year Sharpe Ratio compare to FNF and AXS?
Medibank Pvt's 1-Year Sharpe Ratio of -0.42 can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for an Insurance company?
A good 1-Year Sharpe Ratio depends on the Insurance industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Medibank Pvt and its competitors. Medibank Pvt's current 1-Year Sharpe Ratio is -0.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medibank Pvt stock overvalued right now?
Based on GuruFocus' analysis, Medibank Pvt (ASX:MPL) is currently considered Modestly Overvalued. The stock's GF Value™ is A$4.40, compared to a current price of A$5.04 — trading 14.5% above its estimated fair value. The current 1-Year Sharpe Ratio is -0.42. Medibank Pvt's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Medibank Pvt (ASX:MPL), the current 1-Year Sharpe Ratio is -0.42 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medibank Pvt (ASX:MPL) Overvalued in 2026?

Based on GuruFocus' analysis, Medibank Pvt stock appears to be overvalued. The current stock price of A$5.04 is trading 14.5% above its estimated GF Value™ of A$4.40. GuruFocus considers Medibank Pvt to be Modestly Overvalued.

Key valuation signals for ASX:MPL:

  • 1-Year Sharpe Ratio: -0.42
  • GF Value™: A$4.40 vs. price of A$5.04 (14.5% above fair value)
  • GF Score™: 77/100 with 6 warning signs

No single metric tells the full story. See the ASX:MPL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medibank Pvt Business Description

Other Exchanges MDBPF:USAMDBKY:USA
Address 695 Collins Street, Medibank Melbourne Hub, Level 2, Docklands, Melbourne, VIC, AUS, 3008
Previously owned by the Australian government, Medibank is the largest health insurer in Australia. Its two brands, Medibank Private and Ahm, cover around 5 million people. Medibank and Australia's fourth-largest health fund, NIB Holdings, are the only listed health insurers. In addition to private health insurance, the firm provides life, pet, and travel insurance, as well as health insurance for overseas students and temporary overseas workers. The Medibank Health division provides healthcare services to businesses, governments, and communities across Australia and New Zealand.
77GF Score

Get the complete analysis for ASX:MPL

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$5.04
Price
A$4.40
GF Value